Clinical Trial Update: Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/2 study of sacituzumab govitecan in combination with cisplatin for platinum-sensitive recurrent ovarian and endometri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• TRODELVY (sacituzumab govitecan)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Ovarian Cancer, Malignant Neoplasm of Uterus | Phase 1, Phase 2 | Status: RECRUITING